Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mallesh Pandrala

3PUBLICATIONS

13CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jul 29, 2025

Correction: Afjei et al. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. <i>Cancers</i> 2022, <i>14</i>, 6120.

Rayhaneh Afjei, Negar Sadeghipour, Sukumar Uday Kumar

|Dec 23, 2022

A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations.

Rayhaneh Afjei, Negar Sadeghipour, Sukumar Uday Kumar

|Jun 28, 2022

Reengineering Ponatinib to Minimize Cardiovascular Toxicity.

Anna P Hnatiuk, Arne A N Bruyneel, Dhanir Tailor

Pageof 1

Frequent Collaborators

2 joint publications

Ramasamy Paulmurugan

2 joint publications

Sanjay V Malhotra

1 joint publications

Anna P Hnatiuk

1 joint publications

Arne A N Bruyneel

1 joint publications

Dhanir Tailor

1 joint publications

Ricardo Serrano

1 joint publications

Michelle M Vu

1 joint publications

Yusuke Nakauchi

1 joint publications

Isabel Morgado

1 joint publications

Volker Wiebking

Frequent Collaborators

2 joint publications

Ramasamy Paulmurugan

2 joint publications

Sanjay V Malhotra

1 joint publications

Anna P Hnatiuk

1 joint publications

Arne A N Bruyneel

Top Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on : Dec 30, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos

Top Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on : Dec 30, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos